Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma

The new IASLC/ATS/ERS ADC classification has prognostic value in predicting the recurrence and survival of patients with clinical stage IA ADC. The frequency of stage migration was found in more than half of solid and micropapillary predominant ADCs.